USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Assignor Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Assignor Name : CORIUM PHARMA SOLUTIONS, INC.

Total Assignments: 3

Assignment: 1

Reel/Frame:	061689/0581			Pages:	12
		Recorded:	10/17/2022
Attorney Dkt #:	051285-33030
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Assignor

1

CORIUM PHARMA SOLUTIONS, INC.

Exec Dt:

10/14/2022

Assignee

1

SILICON VALLEY BANK, AS ADMINISTRATIVE AGENT

1437 7TH STREET

SANTA MONICA, CALIFORNIA 90401

Properties

	Pat #	Pub #	Intl #	App #		Pat #	Pub #	Intl #	App #		Pat #	Pub #	Intl #	App #
	7131987	US20020177858		10154686		7828827	US20030220656		10155108		8840918	US20030152528		10359548
	7578954	US20040164454		10373251		7763203	US20040146611		10727124		8541021	US20040258723		10848538
	7572405	US20060076718		10853658		8658201	US20050208110		11047964		7611481	US20050228340		11088829
	9242021	US20060034905		11198468		9308325	US20080091139		11820591		8821446	US20080183144		12009954
	9114238	US20080269685		12148180		8911749	US20090155330		12249795		8481059	US20090258060		12491088
	7914480	US20100028390		12576581		8784879	US20100291186		12687586		8821901	US20100239644		12754331
	9687640	US20110276027		13100924		9687641	US20110276028		13101071		NONE	US20130131598		13732229
	9452280	US20130292868		13939123		11052231	US20140180201		14137899		9144552	US20140147489		14171612
	10245422	US20140276580		14201644		NONE	US20140276378		14201709		10195409	US20140276366		14203378
	10384045	US20140276474		14203429		10384046	US20140276589		14210402		9962534	US20140272101		14214377
	9610253	US20140322284		14323958		9498524	US20150079133		14549442		10238848	US20150297878		14789919
	NONE	US20160058992		14839690		10624843	US20160067176		14843914		9913840	US20160354369		15176080
	10857093	US20160374939		15195793		10238612	US20170165212		15444253		10946180	US20170361079		15633583
	10945968	US20180028466		15660929		11173132	US20190183810		16228641		NONE	US20190184147		16283696
	11110259	US20190184148		16285044		11565097	US20190336741		16513613		11419816	US20200405630		16786906
	NONE	US20200237654		16852193		NONE	US20210086933		17062491		11666740	US20210187263		17185746
	NONE	US20210276228		17255420		12377044	US20230027289		17812995

Correspondence name and address
	DUSAN CLARK, ESQ.
	SIDLEY AUSTIN LLP
	2021 MCKINNEY AVE., SUITE 2000
	DALLAS, TX 75201

Assignment: 2

Reel/Frame:	069479/0197			Pages:	5
		Recorded:	12/03/2024
Attorney Dkt #:	PLSC - MULTIPLE
Conveyance:	CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).

Assignor

1

CORIUM PHARMA SOLUTIONS, INC.

Exec Dt:

06/02/2023

Assignee

1

CORIUM INNOVATIONS, INC.

235 CONSTITUTION DRIVE

MENLO PARK, CALIFORNIA 94025

Properties

Pat #

Pub #

Intl #

App #

Pat #

Pub #

Intl #

App #

Pat #

Pub #

Intl #

App #

NONE

14839690

17812995

NONE

18146973

NONE

18518280

NONE

18626250

NONE

18660496

Correspondence name and address
	COOLEY LLP
	ATTN: IP DOCKETING DEPARTMENT
	1299 PENNSYLVANIA AVENUE, NW, SUITE 700
	WASHINGTON, DC 20004

Assignment: 3

Reel/Frame:	070171/0437			Pages:	4
		Recorded:	02/10/2025
Attorney Dkt #:	PLSC-204/01US
Conveyance:	CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).

Assignor

1

CORIUM PHARMA SOLUTIONS, INC.

Exec Dt:

06/02/2023

Assignee

1

CORIUM INNOVATIONS, INC.

4558 50TH STREET SE

GRAND RAPIDS, MICHIGAN 49512

Properties

Pat #

Pub #

Intl #

App #

Pat #

Pub #

Intl #

App #

13101071

16786906

Correspondence name and address
	COOLEY LLP
	ATTN: IP DOCKETING DEPARTMENT
	1299 PENNSYLVANIA AVENUE NW, SUITE 700
	WASHINGTON, DC 20004

Search Results as of: 10/05/2025 02:30 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6

| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT